슈뢰딩거 (SDGR)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

슈뢰딩거 Stock (SDGR) Company Profile

Schrodinger Inc

Healthcare (1053)

503-299-1150

1540 BROADWAY, NEW YORK, NY

@schrodinger

최신 SEC 제출 서류

SDGR's Discussions on Twitter

Compare SDGR vs VEEV, TEM, BTSG, HNGE, HQY

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
SDGR Schrodinger Inc	26.86	2.01B	254.91M	-103.48M	-148.35M	-1.4036
VEEV Veeva Systems Inc	313.11	50.70B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	71.70	13.07B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	58.63	11.60B	13.65B	169.86M	412.12M	1.0758
HNGE Hinge Health Inc	112.60	9.09B	646.34M	-512.40M	202.76M	-6.6871
HQY Healthequity Inc	102.14	8.45B	1.34B	230.70M	440.96M	2.6695

슈뢰딩거 Stock (SDGR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-08-14	재개	UBS	Neutral
2025-12-15	업그레이드	BofA Securities	Neutral → Buy
2025-09-30	개시	Goldman	Neutral
2025-08-15	다운그레이드	Citigroup	Buy → Neutral
2025-08-14	개시	Barclays	Overweight
2025-07-03	재개	Morgan Stanley	Equal-Weight
2024-07-02	개시	Leerink Partners	Outperform
2023-12-05	개시	KeyBanc Capital Markets	Overweight
2023-05-05	재개	Piper Sandler	Overweight
2022-12-19	개시	Goldman	Neutral
2022-03-01	개시	Citigroup	Buy
2021-11-19	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-11-19	개시	Piper Sandler	Overweight
2021-11-11	다운그레이드	BofA Securities	Buy → Neutral
2021-10-13	개시	Berenberg	Buy
2021-09-01	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-05-25	개시	Craig Hallum	Buy
2020-11-23	업그레이드	BofA Securities	Neutral → Buy
2020-10-12	업그레이드	Jefferies	Hold → Buy
2020-03-02	개시	BMO Capital Markets	Outperform
2020-03-02	개시	Jefferies	Hold
2020-03-02	개시	Morgan Stanley	Equal-Weight

슈뢰딩거 주식(SDGR)의 최신 뉴스

슈뢰딩거 (SDGR) 재무 분석

슈뢰딩거 주식 (SDGR) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Akinsanya Karen	See Remarks	Sep 17 '26	Sale	29.37	31,599	927,970	69,956
KAREN OLUFUNMILYO AKINSANYA-AK	Officer	Sep 17 '26	Proposed Sale	23.93	31,599	756,164	0
Jain Rachit	EVP & CFO	Jul 16 '26	Sale	15.60	875	13,647	50,877
Jain Rachit	Officer	Jul 16 '26	Proposed Sale	15.60	875	13,647	0
Aklian Mannix Vartan	Officer	Jul 01 '26	Proposed Sale	16.68	1,136	18,949	0
Herman Jenny	Officer	May 01 '26	Proposed Sale	12.26	1,957	24,000	0
Farid Ramy	President & CEO	Apr 17 '26	Option Exercise	3.07	117,527	360,808	405,351
Farid Ramy	President & CEO	Apr 17 '26	Sale	12.21	43,000	524,944	330,824
Farid Ramy	President & CEO	Apr 16 '26	Option Exercise	3.07	43,000	132,010	373,824
Farid Ramy	President & CEO	Apr 16 '26	Sale	12.33	43,000	530,233	330,824

슈뢰딩거 (SDGR)

슈뢰딩거 Stock (SDGR) Company Profile

Compare SDGR vs VEEV, TEM, BTSG, HNGE, HQY

슈뢰딩거 Stock (SDGR) Upgrades & Downgrades

슈뢰딩거 주식(SDGR)의 최신 뉴스

Schrödinger to Announce Third Quarter 2026 Financial Results on November 4 - Business Wire

Certara, Inc. (CERT) Stock Price, News, Quote & History - Yahoo! Finance Canada

Up to 40% of lithium ions in battery fluid cluster. This could help guide battery design. - Stock Titan

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Zacks Investment Research

Global Drug Discovery AI Tools MarketStrategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities - GlobeNewswire Inc.

Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.

Early Warning Disclosure Regarding Common Shares of Irruptive Metals Corp. - Yahoo Finance

Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria

Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com South Africa

Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com India

Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan

Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance

Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com

Schrodinger Inc. (SDGR) Pulls Back 4.03% to $29.02, Nearing Key SupportCharm Flow - dars.gov.et

Host Digital Inc. Announces Common Stock Offering - Yahoo Finance

Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Schrödinger Stock Adds 26% and $472 Million of Market Value; Tectora’s Terms Stay Private - TechStock²

Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily

Schrödinger introduces Tectora Therapeutics - BioWorld News

Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace

SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com

A new drug company raises $55 million for oral medicines - Stock Titan

Is Schrodinger Inc (SDGR) a Bargain After 3.1% Drop? GF Value Sa - GuruFocus

Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportPut Flow Alert - dars.gov.et

Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportUp Down Volume - vinanet.vn

Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? - TradingView

“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty - Yahoo Finance

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - PR Newswire

Schrödinger’s Strait - الحرة

Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily

Drug Discovery Platforms Market to Reach USD 16.5 Billion by 2036, Driven by AI-Powered Research and Rising Pharmaceutical R&D Investment - industrytoday.co.uk

Schrödinger to Present at Morgan Stanley Global Healthcare Conference 2026 - BioSpace

Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire

Schrodinger Inc. (SDGR) Slips 1.81% to $20.04 as Stock Holds Above Key SupportInsider Selling Alerts - dars.gov.et

SDGR | Schrodinger, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative

Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) - Seeking Alpha

Tejara Capital Ltd Takes $4.55 Million Position in Schrodinger, Inc. $SDGR - MarketBeat

Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.ca

Schrodinger (NASDAQ:SDGR) Trading 10.4% HigherWhat's Next? - MarketBeat

BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24 - Moomoo

Schrodinger Inc (SDGR) News, Articles, Events & Latest Updates - Stocktwits

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Yahoo Finance

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - The Globe and Mail

Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery - drugdiscoverytrends.com

Schrodinger Inc. (SDGR) Slides 4.7% to $17.59 as Bearish Momentum BuildsCounter Trend Trade - Vinanet

SDGR Looks 29.7% Undervalued on GF Value™ - GuruFocus

슈뢰딩거 (SDGR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

슈뢰딩거 주식 (SDGR) 내부자 거래

SDGR과 유사한 종목